Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2021-09-15 Capital/Financing Update
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
ASA & EMVision Sign $8m Project Agreement 4 pages 235.8KB
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about EMVision Medical Devices Ltd signing a binding Project Agreement with the Australian Stroke Alliance for an $8 million non-dilutive funding project. It describes the terms of the agreement, funding milestones, deliverables, and the nature of the collaboration. The content focuses on a funding and development agreement rather than financial results, management changes, or regulatory filings. It is not a financial report, earnings release, or management discussion. The document is a capital/financing update related to a significant funding agreement and project financing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-09-15 English
Appendix 4E & Annual Report 30 June 2021 53 pages 5.7MB
Annual Report Classification · 100% confidence The document is titled 'EMVision Annual Report 2021' and includes a CEO & Chairman's letter, detailed financial results for the year ended 30 June 2021, a Directors' Report, and comprehensive operational and financial commentary. It contains audited financial statements, detailed discussion of company activities, financial performance, cash flows, and corporate governance information. The presence of a full annual period (year ended 30 June 2021) and extensive financial and operational data confirms this is a full Annual Report. The document is approximately 15,000 characters, indicating it is a full report rather than a brief announcement or summary. Therefore, the correct classification is Annual Report (10-K). FY 2021
2021-08-30 English
Appendix 4G & Corporate Governance Statement 25 pages 530.1KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a detailed governance disclosure document related to the corporate governance statement of Emvision Medical Devices Ltd for the financial year ended 30 June 2021. The document serves as a key to where governance disclosures can be found and verifies compliance with ASX Listing Rules regarding corporate governance disclosures. It is not the corporate governance statement itself but an appendix that accompanies the annual report. The document is not a full annual report, audit report, or any other financial report but a governance-related disclosure document. This fits the definition of a Governance Information filing (CGR), which details the company's internal rules, board structure, and governance practices. The document length (15,000 characters) and content confirm it is a substantive governance disclosure rather than a brief announcement or certification. Therefore, the appropriate classification is CGR with high confidence.
2021-08-30 English
Notification of cessation of securities - EMV 4 pages 24.4KB
Share Issue/Capital Change Classification · 95% confidence The document is a notification about the cessation of certain securities (options) by Emvision Medical Devices Ltd, including details such as the number of securities ceased, the reason for cessation, and the updated issued capital following these changes. It is an announcement related to changes in the company's issued capital and securities but does not contain financial statements or detailed financial performance data. The document is relatively short (4066 characters) and serves as a formal notification to the ASX about securities cessation. This fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as cessation or cancellation of securities.
2021-08-18 English
Application for quotation of securities - EMV 7 pages 31.0KB
Capital/Financing Update Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and whether the securities rank equally with existing shares. The document is a formal announcement related to capital changes, specifically the issuance and quotation of new shares following option exercises. It does not contain financial statements, management discussion, or audit information. Therefore, it fits the category of a capital or financing update regarding securities issuance and quotation.
2021-08-16 English
Cleansing Notice 1 page 129.0KB
Share Issue/Capital Change Classification · 95% confidence The document is a notice from EMVision Medical Devices Ltd regarding the issuance of shares following the exercise of options. It references compliance with sections of the Corporations Act 2001 and mentions an Appendix 2A announcement. The content focuses on a share issue event and legal compliance notices related to securities issuance without disclosure. The document length is short (1708 characters) and it is an announcement rather than a detailed report or financial statement. This fits the category of Share Issue/Capital Change (SHA), which covers announcements about new share issues or capital changes.
2021-08-16 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.